Use of Minimally Invasive Surgery in the Diagnosis and Treatment of Cancer in Dogs and Cats. by Balsa, Ingrid M & Culp, William TN
UC Davis
UC Davis Previously Published Works
Title
Use of Minimally Invasive Surgery in the Diagnosis and Treatment of Cancer in Dogs and 
Cats.
Permalink
https://escholarship.org/uc/item/1x4975q8
Journal
Veterinary sciences, 6(1)
ISSN
2306-7381
Authors
Balsa, Ingrid M
Culp, William TN
Publication Date
2019-03-20
DOI
10.3390/vetsci6010033
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
veterinary
sciences
Review
Use of Minimally Invasive Surgery in the Diagnosis
and Treatment of Cancer in Dogs and Cats
Ingrid M. Balsa * and William T. N. Culp
Department of Surgical and Radiological Sciences, University of California-Davis, 1 Shields Ave.,
Davis, CA 95616, USA; wculp@ucdavis.edu
* Correspondence: imbalsa@ucdavis.edu; Tel.: +530-752-1393
Received: 17 January 2019; Accepted: 8 March 2019; Published: 20 March 2019


Abstract: Surgical management of neoplastic disease is common in veterinary medicine. Minimally
invasive surgery (MIS) has gained widespread acceptance by veterinary surgeons and is experiencing
rapid growth and frequency of use. Many neoplastic diseases in the abdomen and thorax of dogs and
cats can be treated as effectively with MIS as with traditional open surgery. Additionally, MIS allows
for less invasive options for organ biopsy in cancer patients either for initial diagnosis or for staging to
inform prognosis and treatment. Despite the recent increase in MIS, additional research is required to
further characterize the benefits to oncology patients and to ensure that surgical oncologic principles
and patient outcomes are not compromised by the use of MIS.
Keywords: Surgical oncology; neoplasia; minimally invasive surgery; staging; thoracoscopy;
laparoscopy
1. Introduction
Despite the regular use of minimally invasive surgery (MIS)—specifically laparoscopy and
thoracoscopy—in human practice for decades, acceptance of MIS in veterinary medicine as
standard-of-care has occurred more slowly. This is likely multi-factorial and may be associated with the
cost of instrumentation, size of patients and the learning curve of new surgical skills. Initial descriptions
of veterinary diagnostic laparoscopy were published in 1977 [1]; however, it was not until year 2000
that there was widespread acceptance and interest among veterinary surgeons. Since that time there
has been exponential growth in the field for the management of both benign and neoplastic conditions.
Likewise, the discipline of veterinary surgical oncology has grown considerably as a discipline since
the mid-1980s when specific surgical oncology fellowship training was made available to veterinary
surgeons. In oncology patients, the use of MIS is considered desirable due to the potential for decreased
pain, more rapid return to function and potential decreased inflammation following surgery [2,3].
Throughout the veterinary MIS literature, the importance of case selection is evident.
When choosing MIS oncology candidates, considerations must include the size of the tumor, size and
body shape of the patient (e.g., Labrador retriever versus English bulldog), potential presence of
adhesions and the patient’s ability to tolerate a pneumoperitoneum if pulmonary, cardiovascular or
intracranial comorbidities exist.
A wide variety of available instruments are desirable in veterinary MIS due to the variable size of
patients. Port cannulas generally range from 2–12 mm with 5- and 10-mm instruments being most
commonly used. Vessel sealing devices and stapling equipment are regularly used and necessary
for many procedures. Due to the cost of equipment, re-sterilization and reuse of instruments that
are intended for single use (e.g., LigaSureTM handpiece and SILSTM port) is common in veterinary
medicine. There is growing literature to support the safety of this practice [4,5]. Step-by-step
descriptions of surgical procedures are outside the scope of this manuscript; the authors suggest
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further reading in textbooks for more in-depth discussions regarding surgical technique prior to
implementing MIS in a veterinary practice [6]. Additionally, the tumor size guidelines presented in this
manuscript are meant to characterize the knowledge in the current veterinary literature and should
not be taken as absolute recommendations and will vary from patient to patient. Also, as surgeon skill
and sophistication of surgical instruments increase, larger tumors in smaller patients may well be able
to be safely removed utilizing MIS.
2. Laparoscopy
2.1. Splenectomy
The canine spleen is a significantly larger organ relative to body size than the human spleen.
Therefore, although laparoscopic splenectomy has gained widespread acceptance in human medicine
for hematologic conditions and trauma, it is less commonly performed in veterinary patients. The most
common indication for canine splenectomy is presence of a splenic mass. Splenic size combined with
the addition of a mass may be the reason why laparoscopic splenectomy in veterinary patients has
been limited. However, both multi-port and single-incision techniques have been described as well as
total laparoscopic and laparoscopic-assisted techniques. At the time of this writing, 69 laparoscopic
or laparoscopic-assisted canine splenectomies have been described in the literature [7–11]. The most
common reason for having this procedure performed is the presence of a splenic mass. Splenic masses
larger than 6 cm are considered a relative contraindication to MIS as visualization may be impaired by
sheer size and omental adhesion; additionally, the ability to manipulate the spleen may be decreased
potentially leading to a greater chance of splenic rupture. Patient selection is also generally limited to
dogs without a hemoperitoneum due to concerns about visualization.
The most common malignant tumors of the canine spleen are hemangiosarcoma, histiocytic
sarcoma and lymphoma [12]. For these diseases, treatment generally includes splenectomy and
adjuvant chemotherapy. Laparoscopic splenectomy has been described successfully in 3 cats in the
veterinary literature; management of mast cell disease appears to be a common reason to consider this
procedure in cats [13].
At the time of this writing it is unknown if MIS splenectomy alters the outcome of these patients
compared to patients that undergo a splenectomy via open celiotomy. Conversion to an open procedure
may be required in cases of hemorrhage. While this is reported in the human literature it has not been
reported as a reason for conversion in the veterinary literature, likely due to case selection and though
not reported the possibility of ongoing hemorrhage requiring conversion exists in veterinary patients.
The only conversion during a laparoscopic splenectomy reported in the veterinary literature was due
to severe omental adhesions and abundant falciform fat obscuring the surgical field [9]. Post-operative
complications include surgical site bruising, infection and inflammation which may be decreased in
dogs undergoing MIS splenectomy as compared to an open splenectomy although prospective studies
to evaluate this further are needed [9,14].
Proposed benefits of laparoscopic splenectomy include decreased pain following surgery
and decreased rate of infection [14]. Generally short-term outcomes following laparoscopic or
laparoscopic-assisted splenectomy are considered excellent with all reported cases surviving to
discharge. Long-term outcome in dogs with malignant splenic tumors is guarded; however, this
outcome is likely not influenced by the type of splenectomy (MIS vs open) the dog undergoes.
2.2. Adrenalectomy
Laparoscopic adrenalectomy is a common procedure in both human and veterinary medicine
for non-invasive adrenal tumors of small to moderate size. In both human and veterinary patients
multi-port and single-incision laparoscopy has been described; additionally, both transperitoneal and
retroperitoneal approaches have been described in humans and dogs [15,16]. In dogs in which an
adrenal tumor has been diagnosed, the first step is a complete endocrine evaluation to determine
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if the tumor is functional or non-functional. It is important to remember that both adenomas and
carcinomas may be either functional or non-functional, and therefore, despite their benign nature many
veterinary patients diagnosed with adrenal gland adenomas are still reasonable surgical candidates [17].
Currently, approximately 50 clinical laparoscopic adrenalectomy surgeries in dogs and 12 in cats are
described in the veterinary literature [16–20].
Adrenal cortical carcinoma is an aggressive and highly metastatic tumor in humans, with over
20% of patients having nodal or distant metastasis at the time of diagnosis [21]. This is contrary
to canine adrenal cortical carcinoma where less than 14% have evidence of metastasis at the time
of diagnosis [22,23]. In human medicine there are some studies to support that laparoscopic
adrenalectomy may be inferior to open adrenalectomy based on recurrence and disease-free
interval, the long-term outcomes in veterinary patients is not yet known [24–26]. In dogs with
functional cortical carcinomas the most common hormone produced is cortisol, resulting in
hyperadrenocorticism. Clinical signs of hyperadrenocorticism are important differentiators between
functional and non-functional tumors. Diagnosis is via an elevated urine cortisol:creatinine ratio and
either ACTH stimulation or low-dose dexamethasone suppression test. In cats, the most common
adrenal tumor is an aldosterone-secreting tumor which is diagnosed via a plasma aldosterone level.
Pheochromocytoma or a tumor of the chromaffin cells of the adrenal medulla, secretes catecholamines.
These tumors are uncommon in dogs and rare in cats. Urine normetanephrine:creatinine ratio is useful in
differentiating catecholamine secreting tumor and non-functional tumors [27]. Metastasis at diagnosis
in dogs is approximately 20% and reported common locations include the regional lymph nodes, lung,
liver, spleen and kidney [28,29].
Vascular invasion is considered a contraindication to laparoscopic adrenalectomy and this is
encountered more commonly with malignant tumors (e.g., pheochromocytomas and adenocarcinomas)
than adenomas [22,30,31]. Therefore, a contrast computed tomography (CT) angiogram is considered
mandatory as a pre-operative diagnostic by the authors. Relative contraindications to a laparoscopic
technique include tumor size; tumors > 7 cm are generally approached via an open celiotomy, but this
varies somewhat based on the size of the patient and surgeon experience [32]. Additionally, it is
thought that left-sided and cranial pole tumors are easier to resect than right-sided or caudal pole
tumors due to the intimate association of the right adrenal gland with the vena cava and the caudal pole
of the adrenal gland with the renal vasculature. Complications of laparoscopic adrenalectomy include
hemorrhage, which can be life-threatening and require emergent conversion to an open celiotomy and
capsular penetration. The consequence of capsular penetration in veterinary patients is unknown at
this time. Intraoperative complications altering anesthesia during resection of pheochromocytomas can
be attributed to catecholamine release and include changes in blood pressure and cardiac arrhythmias.
To minimize risk of death, pretreatment with phenoxybenzamine has been advocated in open surgery
prior to pheochromocytoma resection [33]. Pancreatitis and thromboembolic complications are
well-documented complications following adrenalectomy and these complications may be decreased
with laparoscopic adrenalectomy compared with open adrenalectomy [17].
2.3. Liver Biopsy
Laparoscopic liver biopsy is a commonly performed procedure for diagnosing a variety of
hepatobiliary diseases in both veterinary and human patients. Hundreds of canine laparoscopic
liver biopsy cases (fewer feline) have been reported in the literature owing to the relative ease of the
procedure and the frequency with which it is performed. The efficacy of laparoscopic liver biopsy has
been shown to be similar to that of biopsy obtained by open celiotomy and superior to that obtained
by percutaneous cutting needle [34].
Laparoscopic liver biopsies have been described using either a multi-port technique or a
single-incision port. Historical contraindications to laparoscopic liver biopsy include thrombocytopenia
(<80,000/dL), increased prothrombin time and/or partial thromboplastin time and ascites. However,
a recent large retrospective study on dogs undergoing laparoscopic liver biopsies did not find any
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difference in outcome in dogs with those contraindications. Additionally, all samples were of sufficient
size for a histopathologic diagnosis [35]. Therefore, these contraindications should be considered on
a patient-by-patient basis, taking into consideration the resources of the hospital and accessibility of
blood products if needed. Liver biopsy of solitary masses may result in substantial hemorrhage and
has been shown to be a risk factor for conversion during diagnostic laparoscopic procedures [36].
The most commonly reported complication of laparoscopic liver biopsy is hemorrhage from
the biopsy site or from splenic laceration during port placement, and the need for conversion to an
open procedure has been documented in 2–7% of dogs [35,37]. Other complications include port site
infection or inflammation. Short-term outcomes of laparoscopic liver biopsy are excellent, with >95% of
patients surviving to discharge; non-survival is more frequently due to progression of the underlying
disease and not from complications arising from laparoscopic liver biopsy.
2.4. Renal Biopsy/Nephrectomy
Laparoscopic renal biopsy is performed in veterinary medicine for a variety of diseases including
neoplasia but is more commonly performed for dogs and cats experiencing proteinuria, unexplained
renomegaly and infiltrative renal disease [38]. Common renal tumors in dogs include renal cell
carcinoma, transitional cell carcinoma and metastatic lesions. In cats the most common renal neoplasia
is lymphoma. Alternatives to laparoscopy for renal biopsies exist, including ultrasound-guided needle
biopsies; however one study demonstrated improved sample quality with laparoscopic-acquired
biopsy as compared to ultrasound-guided biopsy [39]. Benefits of laparoscopy over ultrasound may
also include control of hemorrhage at the biopsy site due to the ability to apply direct pressure to the
site and direct visualization of the lesion. Laparoscopic renal biopsy has been described using a single
or multi-port technique and ideally a 16-gauge spring-loaded automated biopsy needle [40].
Contraindications for renal biopsy are severe anemia, stage 4 chronic kidney disease, coagulopathy,
hypertension, hydronephrosis, pyelonephritis and cystic renal disease. Complications associated
with renal biopsy include non-diagnostic samples, hemorrhage, hematuria, perirenal hematoma,
hydronephrosis, infarction, ureteral laceration, urinary obstruction secondary to blood clot formation
and decreased renal function; complication rates range from 1–20% [38,41].
Laparoscopic ureteronephrectomy is another uncommon surgery that may be performed in cases
of unilateral renal neoplasia in dogs and cats. This surgery, combined with removal of regional
lymph nodes and surrounding tissue, including potentially the ipsilateral adrenal gland, is commonly
performed in human patients with renal cell carcinoma [42,43]. Within the human literature, dogs have
been used as an experimental model of laparoscopic ureteronephrectomy and have been shown to have
decreased surgical stress compared with those undergoing open surgeries [44]. Surgical descriptions in
dogs include multi-port techniques and case selection for neoplasia has been limited to 7 cm unilateral
lesions with very large tumors being considered a contraindication to laparoscopic surgery [45]. Both a
renal cystadenocarcinoma and an infiltrative epithelial neoplasm have been laparoscopically removed
in dogs. Contraindications other than tumor size may include severe hydronephrosis/hydroureter or
severe pyelonephritis or infection extending beyond the renal capsule.
Conversion rate of laparoscopic ureteronephrectomy in the literature is 22% which suggests this is
a technically challenging surgery [45]. Other complications include hemorrhage and port site infection.
Reports of port site metastasis following removal of renal cell carcinoma exist in the human literature,
however, this has not yet been reported in veterinary medicine [46].
2.5. Ovariohysterectomy/Cryptorchidectomy
Laparoscopic ovariohysterectomy and cryptorchidectomy are commonly performed as elective
sterilization surgeries in veterinary medicine. Therefore, reproductive tumors in the dog and cat are
much less common than they are in human medicine. Regardless, laparoscopy has been used for
removal of tumors of the female reproductive system. There is a single case report of laparoscopic
removal of a 7 cm ovarian teratoma via a laparoscopic-assisted ovariohysterectomy [47]. Although not
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reported in the veterinary literature, it is also reasonable to consider that laparoscopy could be used to
excise small to moderately sized uterine tumors.
Cryptorchidism is a congenital abnormality in dogs that may be unilateral or bilateral. For testicles
retained with in the abdomen neoplastic conversion is 13.6 times more likely compared with testicles
in the scrotum of dogs [48]. Laparoscopic cryptorchidectomy has been reported with both multi-port
and single incision techniques. Laparoscopic cryptorchidectomy has been utilized for the removal of
a seminoma, interstitial cell tumor and testicular mixed cell tumor in dogs [49]. Prognosis for all of
these tumor types is excellent with complete excision. Due to the congenital nature of cryptorchidism,
both testicles should always be removed.
Due to the lack of numbers, no definitive case selection criteria for reproductive neoplasia
requiring ovariohysterectomy or cryptorchidectomy is available. However, size of tumor relative
to size of dog should be taken into account as well as ability to obtain acceptable surgical margins,
as surgical oncologic principles should not be sacrificed for the sake of performing a minimally
invasive procedure.
3. Thoracoscopy
3.1. Lung Lobectomy
Lung lobectomy both via video-assisted thoracoscopic surgery (VATS) and by a totally
thoracoscopic technique has been reported in dogs for the removal of primary lung tumors and
metastatic pulmonary lesions [50–52]. These techniques are most appropriate for smaller masses that
are located at the periphery of the lung lobe [50–52]. The minimally invasive technique described for
lung lobectomy has utilized multiple ports. Successful thoracoscopy also often requires placement
of bronchial blockers for one-lung ventilation (OLV) and an understanding of the physiologic
consequences that accompany this procedure. One-lung ventilation is considered important because it
allows for better visualization of the mass and the hilus of the lung and increases the working space
within the chest [53]. Currently in the veterinary literature thoracoscopic lung lobectomy has been
reported in 22 dogs with neoplasia, with carcinoma being diagnosed most commonly followed by
histiocytic sarcoma [50,51]. This is similar to previous reports in which adenocarcinomas were found
to be the most common lung tumors in dogs [54]. Lung tumors and metastatic lesions up to 7 cm
in size have been removed thoracoscopically [50]. Currently in the veterinary literature VATS lung
lobectomy has been reported in over 30 dogs with tumor volumes up to 174.4 cm3 being successfully
resected [52,55–57].
Contraindications to thoracoscopy in companion animals have not been fully elucidated, however
in humans, these include diffuse body wall neoplasia or pleural adhesions and respiratory compromise
with subsequent inability to tolerate OLV. With regards to tumor characteristics, very large tumors
or those close to the hilus have been considered poor candidates for MIS [53]. Due to the inability to
perform a thorough thoracic exploration, the authors believe that a thoracic CT scan is a mandatory
pre-operative diagnostic to identify metastatic disease either within the lung lobe being treated,
in other lung lobes or within regional lymph nodes. Complications include the need for conversion
to an open thoracotomy, with reported conversion rate estimates ranging from 23–44% [50,51].
Reasons for conversion include hemorrhage (intercostal artery), failure to maintain OLV and poor
access/visualization due to location of the tumor [50,51]. This is slightly higher than conversion rates
in the human literature (18%) for VATS resection of primary lung tumors [58]. Other complications
include port site inflammation and infection; infection in these cases can extend into the thoracic cavity
and result in pyothorax. There has been no significant differences identified between dogs that had
lung tumors removed via thoracoscopy or VATS or via open thoracotomy [50,52]. This is similar to the
current human literature in which both morbidity and mortality outcomes appear to be similar for
MIS versus open thoracotomy [58,59].
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MIS lung biopsies have been described for diffuse pulmonary disease as well as small peripheral
neoplastic masses. Loop ligatures, stapling devices and vessel sealing devices have all been used for
peripheral lung biopsies [60,61].
3.2. Mediastinal Masses
Thoracoscopic removal of mediastinal masses has been reported in both the dog and the
cat [62]. The most common mediastinal mass in the dog is thymoma followed by lymphoma.
The most common mediastinal mass in the cat is lymphoma and therefore, mediastinal masses
are less commonly surgically removed in cats. Other potential neoplastic mediastinal masses include
carcinoma, most commonly of thyroid origin and hemangiosarcoma, among others [62]. In the
18 dogs reported in one study, the largest tumor removed thoracoscopically had a tumor volume of
313.3 cm3 [62].
Complications associated with mediastinal mass excision include the need for conversion which
occurred in 11% of dogs in one study [62]. Another interesting complication is port site metastasis
which occurred in one dog 6.5 months following thoracoscopic thymoma removal [63] and in one dog
following thoracoscopic pleural and mediastinal biopsy [64]. Port site metastasis is more commonly
reported in human medicine (~1% of MIS cases) than in veterinary medicine potentially due to the life
span of the patient. The cause of port site metastasis is incompletely understood but likely includes
level of patient debilitation, presence of disseminated disease, contamination of the cannulas with
highly exfoliative tumor cells or contamination of the portal incisions during unprotected tumor
removal. Additionally, the ‘chimney effect’ due to the expulsion of insufflation gas droplets at portal
sites is suspected in cases where insufflation is utilized. Neither of the two case reports of thoracoscopic
port site metastasis involved insufflation. In one dog, a large amount of pleural effusion existed and
this may have played a role in the development of the metastasis [64].
3.3. Right Auricular Mass Resection and Pericardiectomy
Thoracoscopic right auricular mass resection has been described in 10 dogs in the veterinary
literature with good short-term outcome [65,66]. Multi-port techniques have been described with
lesions up to 2 cm in size located at the apex of the right auricle. Short-term outcomes appear good with
this technique with 9 of 10 dogs surviving surgery, however this is likely highly dependent on surgeon
skill. Long-term outcome is guarded as 9 of the 10 lesions were consistent with hemangiosarcoma and
those dogs had a mean survival time of 90 days (range, 0 to 251 days) [65]. This is similar to survival
time reported for dogs undergoing right auricular hemangiosarcoma resection via open thoracotomy
when followed by adjuvant chemotherapy [67].
The major potential complication with thoracoscopic right auricular mass removal is hemorrhage,
which will quickly become life threatening if there is rupture of the right atrium or failure of the
surgical staple line. Additional complications include port site infection or inflammation which is
particularly important in these patients as it can delay initiation of systemic chemotherapy.
A pericardial window is performed prior to right auricular mass resection, with the purposes
of relieving cardiac tamponade and allowing full evaluation of the size and location of the mass via
pericardioscopy. If the mass lesion is large or approaching the base of the auricle, conversion to an open
thoracotomy should be pursued [68]; if the mass is not surgically resectable the pericardial window
may be palliative in the short-term. A pericardial window or subphrenic pericardiectomy may prolong
survival time in dogs with aortic body tumors [69]; this same advantage has not been appreciated in
dogs diagnosed with right auricular hemangiosarcoma if the primary mass is not removed at the time
of surgery [70].
A multi-port thoracoscopic technique has been described with patients positioned in both
dorsal and lateral recumbency. Determining the amount of pericardium to remove is controversial
with current recommendations on the side of “more is better” in cases of idiopathic pericardial
effusion [71,72]. This is likely less of a concern in cases with effusion secondary to neoplasia due
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to the overall shorter expected survival times in this patient population. In one study, removal of
a 4 × 5 cm piece of pericardium was considered sufficient for palliation of clinical signs [73]. If a
definitive diagnosis has not been obtained prior to surgery, a subphrenic pericardiectomy is preferable.
A novel technique of pericardial window with vertical pericardial fillets has been reported in dogs but
not evaluated for neoplastic pericardial effusions [74].
Contraindications to performing a thoracoscopic pericardiectomy may include patients that are
unable to undergo OLV due to cardiac or respiratory disease. However, a subphrenic pericardiectomy
can be performed safely in a dog without OLV [75]. Breed conformation is likely a major factor with
regards to working space with barrel-chested dogs having limited space compared with deep-chested
dogs. This lack of space is exacerbated in cases when the pericardium is distended with fluid.
Therefore, pre-operative pericardiocentesis is advised prior to thoracoscopy; additionally, fluid
drainage will improve cardiovascular stability during anesthesia [76]. Complications specific to
thoracoscopic pericardiectomy include fatal ventricular arrhythmias, thought to be secondary to use of
an electrocautery device, hemorrhage and damage to the phrenic nerve.
4. Lymph Node Staging
Knowledge of lymph node metastasis in cancer patients is important staging information with
tumor, node, metastasis (TNM) systems described for several tumor types. Lymph node metastasis is
often determined via ultrasound-guided fine needle aspiration and cytology. However, this modality
may be difficult for certain lymph nodes especially if small or near vital structures. Laparoscopic
lymphadenectomy allows for the added benefits of direct visualization, potentially minimizing damage
to surrounding tissue and the acquisition of larger tissue samples for histopathology.
Options for lymph node removal include both locoregional lymph nodes and sentinel lymph
nodes. Historically locoregional lymph nodes have been removed in veterinary patients if they are
grossly enlarged, known to be metastatic or if easily accessible through the primary incision site.
This technique may under-stage patients due to lack of detection of micrometastasis in lymph nodes
of normal size. Additionally, while it seems reasonable that locoregional lymph nodes would be the
most likely to contain metastasis, sentinel lymph node mapping in veterinary medicine has shown
that the regional lymph node is not always the sentinel lymph node [77,78]. The sentinel lymph node
is defined as the first node to receive afferent lymphatic drainage from the tumor and can be variable.
Therefore, if the sentinel lymph node is free of metastasis, it is reasonable to consider other lymph
nodes free of metastasis. Sentinel lymph node mapping is widely used in human oncology patients,
initially described for use in breast cancer and melanoma, however it is now used for many different
tumor types and locations [79].
While many pre-operative imaging techniques for sentinel lymph node mapping have
been described, intra-operative imaging including lymphoscintigraphy, blue dye techniques and
near-infrared imaging dyes many be considered more useful to the surgeon especially when dissecting
lymph nodes that are not enlarged as they may aid in visualization and differentiation from
surrounding fat. Regardless of what technique is chosen a small amount of dye is injected peritumorally
and within seconds to minutes uptake should be visualized within the lymphatics and eventually the
sentinel lymph node [80,81].
The most common interface of sentinel lymph node mapping and MIS in veterinary medicine
includes the iliosacral lymphatic center in dogs with apocrine gland anal sac adenocarcinoma in which
nodal metastasis is common. A multi-port technique has been described in both experimental dogs
with normal sized lymph nodes and clinical patients [82,83]. Sentinel lymph node mapping has also
been employed during thoracoscopic removal of tracheobronchial lymph nodes in dogs and cats with
pulmonary carcinomas [81,83].
Complications of MIS lymph node removal include rupture or tearing of the lymph node
leading to regional seeding, and hemorrhage and damage to adjacent structures, including ureters,
when dissection of medial iliac lymph nodes is being performed.
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5. Future Directions
Given its relatively recent adoption in veterinary medicine, MIS has proven useful for many
aspects of veterinary surgical oncology. However, as is apparent in this review, case numbers
are lacking for many techniques. In the few studies that do compare patient outcomes between
MIS and open surgical oncology procedures there does not appear to be a difference in patient
outcomes, and MIS may afford additional benefits such as patient comfort and faster return to
function. More prospective studies are needed to fully understand the benefits of MIS in veterinary
oncology patients. Given the additional costs and training associated with MIS techniques it is
possible that it may not gain as widespread acceptance and practice in veterinary medicine as it has in
human medicine.
MIS has opened the veterinary community to other palliative treatment options for cancer
including MIS-assisted thermal ablation and the combination of MIS and interventional radiology
techniques. As mentioned previously, much research is needed regarding use of these different
modalities in veterinary medicine.
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